Senti Biosciences Holdings, Inc.
SNTI
$0.30
-$0.02-5.32%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 6.61M | 9.13M | 16.74M | 12.78M | 21.67M |
| Total Receivables | 557.00K | 765.00K | 1.60M | 1.74M | 3.69M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 5.56M | 4.90M | 4.94M | 3.64M | 7.16M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 288.00K | -- | -- | -- | -- |
| Total Current Assets | 13.01M | 14.79M | 23.27M | 18.16M | 32.52M |
|
|
|||||
| Total Current Assets | 13.01M | 14.79M | 23.27M | 18.16M | 32.52M |
| Net Property, Plant & Equipment | 18.67M | 19.92M | 24.40M | 30.95M | 32.44M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.43M | 3.53M | 3.55M | 3.57M | 3.58M |
| Total Assets | 33.11M | 38.24M | 51.22M | 52.69M | 68.54M |
|
|
|||||
| Total Accounts Payable | 2.25M | 1.05M | 2.94M | 1.77M | 1.02M |
| Total Accrued Expenses | 3.57M | 4.89M | 5.28M | 5.04M | 3.58M |
| Short-term Debt | 3.99M | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 3.49M | 5.89M | 5.33M | 5.15M | 4.98M |
| Total Finance Division Other Current Liabilities | 2.46M | 2.44M | 420.00K | 62.00K | 413.00K |
| Total Other Current Liabilities | 2.46M | 2.44M | 420.00K | 62.00K | 413.00K |
| Total Current Liabilities | 15.77M | 14.27M | 13.97M | 12.03M | 9.99M |
|
|
|||||
| Total Current Liabilities | 15.77M | 14.27M | 13.97M | 12.03M | 9.99M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 3.99M | -- | -- | -- | -- |
| Capital Leases | 12.74M | 13.25M | 23.56M | 24.97M | 26.33M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 8.00M | 8.16M | 8.10M | 7.57M | 7.57M |
| Total Liabilities | 36.51M | 35.68M | 45.63M | 44.56M | 43.89M |
|
|
|||||
| Common Stock & APIC | 372.14M | 365.36M | 364.16M | 352.23M | 350.63M |
| Retained Earnings | -375.54M | -362.79M | -358.57M | -344.11M | -325.98M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -3.40M | 2.57M | 5.59M | 8.12M | 24.65M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -3.40M | 2.57M | 5.59M | 8.12M | 24.65M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -3.40M | 2.57M | 5.59M | 8.12M | 24.65M |
|
|
|||||